Keros Therapeutics (NASDAQ:KROS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Keros Therapeutics (KROS) operate in?

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.

Open	$53.35
Close	$55.92
Volume / Avg.	402.52K / 367.21K
Day Range	$53.06 - $57.33
52 Wk Range	27.31 - 73.00
Market Cap	$2.27B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	8.11%
Days to Cover	7.7

Recent News

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth

Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$53.35
Close	$55.92
Volume / Avg.	402.52K / 367.21K
Day Range	$53.06 - $57.33
52 Wk Range	27.31 - 73.00
Market Cap	$2.27B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	8.11%
Days to Cover	7.7

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Keros Therapeutics (KROS) stock?

You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.

View our list of the best stock brokerages

Who are Keros Therapeutics (KROS) competitors?

Other companies in Keros Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Keros Therapeutics (KROS) stock?

Keros Therapeutics has a consensus price target of $90.70.

What is the current price for Keros Therapeutics (KROS)?

The stock price for Keros Therapeutics (NASDAQ: KROS) is $55.92 last updated November 22, 2024 at 4:48 PM EST.

Does Keros Therapeutics (KROS) pay a dividend?

There are no upcoming dividends for Keros Therapeutics.

When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?

Keros Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Keros Therapeutics (KROS) going to split?

There is no upcoming split for Keros Therapeutics.

What sector and industry does Keros Therapeutics (KROS) operate in?

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Keros Therapeutics

Keros Therapeutics (KROS) Forecast